Skip to main content

Advertisement

Log in

Determination of L-selectin in blood plasma using DNA aptamer–based surface-enhanced Raman spectroscopy assay

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

In the human body, tumor cell occurrence can be indirectly monitored using the L-selectin concentration in the blood, since selectin ligands are present on the surface of tumor cells, and with tumor progression, a decrease in L-selectin levels can be expected and observed. In this study, we present a selective DNA-based surface-enhanced Raman spectroscopy (SERS) assay for the detection and determination of L-selectin in biological samples. Two calibration curves (linear in the 40–190 ng mL−1 region and exponential in the 40–500 ng mL−1 region) are fitted to the obtained SERS experimental data, i.e., the ratio of I732/I1334 band intensities (LOQ = 46 ng mL−1). Calculated determination coefficients are found to be R2 = 0.997 for the linear region of the calibration curve and R2 = 0.977 for the exponential region. Moreover, we demonstrate very good selectivity of the assay even in the presence of P- and E-selectin in a sample containing L-selectin. With our SERS assay, the L-selectin concentration in biological samples can be estimated directly from the calibration curves.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–98.

    Article  CAS  PubMed  Google Scholar 

  2. Iwata Y, Suzuki K, Nakamura K, Matsuzaki H, Sekine Y, Tsuchiya KJ, Sugihara G, Kawai M, Minabe Y, Takei N, Mori N. Increased levels of serum soluble L-selectin in unmedicated patients with schizophrenia. Schizophr Res. 2007;89:154–60.

    Article  PubMed  Google Scholar 

  3. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184(1–2):53–68.

    Article  CAS  PubMed  Google Scholar 

  4. Borsig L. Selectins in cancer immunity. Glycobiology. 2018;28(9):648–55.

    Article  CAS  PubMed  Google Scholar 

  5. Boligan KF, Mesa C, Fernandez LE, Von Gunten S. Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense. Cell Mol Life Sci. 2015;72:1231–48.

    Article  CAS  PubMed  Google Scholar 

  6. Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15(9):540–55.

    Article  CAS  PubMed  Google Scholar 

  7. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol. 2004;22:129–56.

    Article  CAS  PubMed  Google Scholar 

  8. Sperandio M, Smith ML, Forlow SB, Olson TS, Xia L, McEver RP, Ley K. P-selectin glycoprotein ligand-1 mediates L-selectin–dependent leukocyte rolling in venules. J Exp Med. 2003;197(10):1355–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Majchrzak-Baczmańska DB, Głowacka E, Wilczyński M, Malinowski A. Serum concentrations of soluble (s)L- and (s)P-selectins in women with ovarian cancer. Menopause Rev. 2018;17(1):11–7.

    Article  Google Scholar 

  10. Choudhary D, Hegde P, Voznesensky O, Choudhary S, Kopsiaftis S, Claffey KP, Pilbeam CC, Taylor JA III. Increased expression of L-selectin (CD62L) in high grade urothelial carcinoma: a potential biomarker for metastatic disease. Urol Oncol. 2015;33(9):387.e17-389.e27.

    Article  CAS  PubMed  Google Scholar 

  11. Korniluk A, Kamińska J, Kiszło P, Kemona H, Dymicka-Piekarska V. Lectin adhesion proteins (P-, L- and E-selectins) as biomarkers in colorectal cancer. Biomarkers. 2017;22(7):629–34.

    CAS  PubMed  Google Scholar 

  12. Haznedaroǧlu IC, Benekli M, Ozcebe O, Savaş MC, Güllü IH, Dündar SV, Kirazli Ş. Serum L-selectin and P-selectin levels in lymphomas. Haematologia (Budap). 2000;30(1):27–30.

    Article  PubMed  Google Scholar 

  13. Clark WM, Lauten JD, Lessov N, Woodward W, Coull BM. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol Chem Neuropathol. 1995;26(3):213–30.

    Article  CAS  PubMed  Google Scholar 

  14. Nishijima KI, Ando M, Sano S, Hayashi-Ozawa A, Kinoshita Y, Iijima S. Costimulation of T-cell proliferation by anti-L-selectin antibody is associated with the reduction of a cdk inhibitor p27. Immunology. 2005;116(3):347–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Nicholson MW, Barclay AN, Singer MS, Rosen SD, van der Merwe PA. Affinity and kinetic analysis of L-selectin (CD62L) binding to glycosylation-dependent cell-adhesion molecule-1. J Biol Chem. 1998;273(2):763–770.

  16. Cywiński PJ, Olejko L, Löhmannsröben HG. A time-resolved luminescent competitive assay to detect L-selectin using aptamers as recognition elements. Anal Chim Acta. 2015;887:209–15.

    Article  PubMed  Google Scholar 

  17. Kowalska AA, Nowicka AB, Szymborski T, Piecyk P, Kamińska A. SERS-based sensor for direct L-selectin level determination in plasma samples as alternative method of tumor detection. J Biophotonics. 2021;14(1):1–10.

    Article  Google Scholar 

  18. Le Ru EC, Etchegoin PG. Quantifying SERS enhancements. MRS Bull. 2013;38(8):631–40.

    Article  Google Scholar 

  19. Chen Y, An Q, Teng K, Liu C, Sun F, Li G. Application of SERS in in-vitro biomedical detection. Chem Asian J. 2023;18(4): e202201194.

    Article  CAS  PubMed  Google Scholar 

  20. Perumal J, Wang Y, Attia ABE, Dinish US, Olivo M. Towards a point-of-care SERS sensor for biomedical and agri-food analysis applications: a review of recent advancements. Nanoscale. 2021;13:553–80.

    Article  CAS  PubMed  Google Scholar 

  21. Wan Y, Arif Iftakher MM, Li N, Allen PB, Kim Y, Bachoo R, Iqbal SM, Ellington AD. Nano-textured substrates with immobilized aptamers for cancer cell isolation and cytology. Cancer. 2012;118(8):1145–54.

    Article  CAS  PubMed  Google Scholar 

  22. Nuzzo S, Brancato V, Affinito A, Salvatore M, Cavaliere C, Condorelli G. The role of RNA and DNA aptamers in glioblastoma diagnosis and therapy: a systematic review of the literature. Cancers (Basel). 2020;12(8):1–17.

    Article  Google Scholar 

  23. Affinito A, Quintavalle C, Esposito CL, Roscigno G, Vilardo C, Nuzzo S, Vitiani LR, De Luca G, Pallini R, Kichkailo AS, Lapin IN, de Franciscis V, Condorelli G. The discovery of RNA aptamers that selectively bind glioblastoma stem cells. Mol Ther Nucleic Acids. 2019;18:99–109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Szymborski T, Stepanenko Y, Niciński K, Piecyk P, Berus SM, Adamczyk-Popławska M, Kamińska A. Ultrasensitive SERS platform made via femtosecond laser micromachining for biomedical applications. J Mat Res Tech. 2021;12:1496–507.

    Article  CAS  Google Scholar 

  25. Riese SB, Buscher K, Enders S, Kuehne C, Tauber R, Dernedde J. Structural requirements of mono- and multivalent L-selectin blocking aptamers for enhanced receptor inhibition in vitro and in vivo. Nanomed Nanotechnol Biol Med. 2016;12(4):901–908.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aneta Aniela Kowalska.

Ethics declarations

Ethics approval

Measurement for clinical samples was performed in compliance with the relevant laws and institutional guidelines. The protocol of study was approved by the Ethics and Bioethics Committee of Cardinal Stefan Wyszynski University in Warsaw (Poland): Opinion number 13/2019.

Source of biological material

Plasma samples from patients with tumor were collected according to standard best practice and ethics and bioethics guidelines. Informed consent was obtained from all subjects.

Plasma samples from patients with tumor are gathered by the Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, (Lublin, Poland). Human plasma blood samples from 3 healthy patients (healthy tissue samples) were acquired from Regional Blood Center in Warsaw, Poland.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 3550 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kowalska, A.A., Nowicka, A.B., Szymborski, T. et al. Determination of L-selectin in blood plasma using DNA aptamer–based surface-enhanced Raman spectroscopy assay. Anal Bioanal Chem 416, 1189–1197 (2024). https://doi.org/10.1007/s00216-023-05110-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-023-05110-x

Keywords

Navigation